Published in Am J Pathol on May 01, 1989
Expression of the human nephron differentiation molecules in renal cell carcinomas. Am J Pathol (1990) 1.11
CD10/neutral endopeptidase 24.11 in developing human fetal lung. Patterns of expression and modulation of peptide-mediated proliferation. J Clin Invest (1992) 1.03
Expression of aminopeptidase N (CD13) in mesenchymal tumors. Am J Pathol (1990) 0.90
Decreased expression of messenger RNAs encoding endothelin receptors and neutral endopeptidase 24.11 in endometrial cancer. Br J Cancer (1995) 0.90
Can CD10 be used as a diagnostic marker in thyroid pathology? Virchows Arch (2008) 0.79
Diagnostic value of CD-10 marker in differentiating of papillary thyroid carcinoma from benign thyroid lesions. Adv Biomed Res (2014) 0.76
CD10+ stromal cells in fibroadenomas and phyllodes tumors of the breast. Virchows Arch (2006) 0.75
Antisera to acute lymphoblastic leukemia cells. Clin Immunol Immunopathol (1975) 3.12
Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues. J Exp Med (1981) 1.85
Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase. J Exp Med (1988) 1.77
Expression of HLA-DR and common acute lymphoblastic leukemia antigens on glioma cells. Eur J Immunol (1982) 1.62
Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage. Blood (1981) 1.57
A small polypeptide different from beta2-microglobin associated with a human cell surface antigen. Nature (1979) 1.49
Molecular cloning of the common acute lymphoblastic leukemia antigen (CALLA) identifies a type II integral membrane protein. Proc Natl Acad Sci U S A (1988) 1.41
Malignant fibrous histiocytoma tumor cells resemble fibroblasts. Am J Surg Pathol (1986) 1.28
Identification of myoepithelial cells in human and rat breasts by anti-common acute lymphoblastic leukemia antigen antibody A12. J Natl Cancer Inst (1986) 1.20
Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation. Blood (1987) 1.12
Granulocytes and cultured human fibroblasts express common acute lymphoblastic leukemia-associated antigens. Blood (1983) 1.12
Expression of common acute lymphoblastic leukemia antigen (CALLA) on human malignant melanoma cell lines. J Immunol (1983) 1.10
Structure/function studies of the common acute lymphoblastic leukemia antigen (CALLA/CD10) expressed on human neutrophils. J Immunol (1986) 1.01
Expression of the common acute lymphoblastic leukaemia antigen (CALLA gp100) in the brush border of normal jejunum and jejunum of patients with coeliac disease. J Clin Pathol (1985) 1.01
Distribution and modulation of a human leukemia-associated antigen (CALLA). J Immunol (1983) 0.96
Cultured marrow stromal cells express common acute lymphoblastic leukaemia antigen (CALLA): implications for marrow transplantation. Br J Haematol (1983) 0.91
Expression of common acute lymphoblastic leukemia-associated antigen on germ cell tumor. Am J Med (1986) 0.88
Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (1989) 7.76
Constitutive and induced expression of APO-1, a new member of the nerve growth factor/tumor necrosis factor receptor superfamily, in normal and neoplastic cells. Lab Invest (1993) 3.13
Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation. Int J Obes Relat Metab Disord (2001) 2.94
Immunohistochemical study of the expression of a Mr 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissues. Cancer Res (1987) 2.22
T cell awareness of paternal alloantigens during pregnancy. Science (1995) 2.12
Cryobiopsy increases the diagnostic yield of endobronchial biopsy: a multicentre trial. Eur Respir J (2011) 2.09
Genomic imbalances including amplification of the tyrosine kinase gene JAK2 in CD30+ Hodgkin cells. Cancer Res (2000) 2.09
Prospective evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy (1999) 2.02
Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol (1992) 1.94
Primary mediastinal (thymic) B-cell lymphoma is characterized by gains of chromosomal material including 9p and amplification of the REL gene. Blood (1996) 1.85
Differential expression of Ia and Ia-associated invariant chain in mouse tissues after in vivo treatment with IFN-gamma. J Immunol (1986) 1.82
CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: a possible role in ulcerative colitis. Gastroenterology (1997) 1.81
Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation. Oncogene (2006) 1.79
Human major histocompatibility complex class II invariant chain is expressed on the cell surface. J Biol Chem (1990) 1.77
Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1. Genes Chromosomes Cancer (2001) 1.61
Gain of chromosome arm 9p is characteristic of primary mediastinal B-cell lymphoma (MBL): comprehensive molecular cytogenetic analysis and presentation of a novel MBL cell line. Genes Chromosomes Cancer (2001) 1.49
Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer. Int J Cancer (1986) 1.48
T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas. J Immunol (1998) 1.44
Genomic imbalances are rare in hairy cell leukemia. Genes Chromosomes Cancer (1999) 1.39
Estimation of surface area and length with the orientator. J Microsc (1990) 1.38
The stem cell-associated Hiwi gene in human adenocarcinoma of the pancreas: expression and risk of tumour-related death. Br J Cancer (2008) 1.36
Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype. J Immunol (1999) 1.34
Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. Br J Cancer (1987) 1.30
Sex-specific telomere length profiles and age-dependent erosion dynamics of individual chromosome arms in humans. Cytogenet Genome Res (2006) 1.24
Rapid intracellular pathway gives rise to cell surface expression of the MHC class II-associated invariant chain (CD74). J Immunol (1991) 1.23
Expression of VLA-alpha 2, VLA-alpha 6, and VLA-beta 1 chains in normal mucosa and adenomas of the colon, and in colon carcinomas and their liver metastases. Am J Pathol (1991) 1.22
Colon carcinoma cells use different mechanisms to escape CD95-mediated apoptosis. Cancer Res (1998) 1.21
Rapid onset of apoptosis in vitro follows disruption of beta 1-integrin/matrix interactions in human colonic crypt cells. Gastroenterology (1996) 1.17
In vivo induction of H-2K/D antigens by recombinant interferon-gamma. Eur J Immunol (1986) 1.15
Lipoid pneumonia: an occupational hazard of fire eaters. Br Med J (Clin Res Ed) (1985) 1.13
Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy. Int J Cancer (1987) 1.13
Selective loss of HLA-A or HLA-B antigen expression in colon carcinoma. J Immunol (1989) 1.13
Mediastinal lymphoma of clear cell type is a tumor corresponding to terminal steps of B cell differentiation. Blood (1987) 1.12
In situ detection of enterocytic apoptosis in normal colonic mucosa and in familial adenomatous polyposis. Gut (1995) 1.12
Expression of the natural killer cell-associated antigens CD56 and CD57 in human neural and striated muscle cells and in their tumors. Cancer Res (1991) 1.11
Therapy-related acute promyelocytic leukemia with t(15;17) (q22;q12) following chemotherapy with drugs targeting DNA topoisomerase II. A report of two cases and a review of the literature. Ann Oncol (1995) 1.10
Absence of the JAK2 V617F activating mutation in classical Hodgkin lymphoma and primary mediastinal B-cell lymphoma. Leukemia (2006) 1.06
Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients. J Clin Oncol (1997) 1.05
Delineation of the 6p22 amplification unit in urinary bladder carcinoma cell lines. Cancer Res (2000) 1.05
Gains of the proto-oncogene BCL11A and nuclear accumulation of BCL11A(XL) protein are frequent in primary mediastinal B-cell lymphoma. Leukemia (2006) 1.04
Clustering of colonic lamina propria CD4(+) T cells to subepithelial dendritic cell aggregates precedes the development of colitis in a murine adoptive transfer model. Lab Invest (2001) 1.03
Activating immunity in the liver. I. Liver dendritic cells (but not hepatocytes) are potent activators of IFN-gamma release by liver NKT cells. J Immunol (2001) 1.02
Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens. Immunology (1995) 1.02
High incidence of chromosomal imbalances and gene amplifications in the classical follicular variant of follicle center lymphoma. Blood (1996) 1.01
Lectin target cells in human central nervous system and the pituitary gland. Histochemistry (1984) 1.01
Differential effects of caspase-1/interleukin-1beta-converting enzyme on acinar cell necrosis and apoptosis in severe acute experimental pancreatitis. Lab Invest (2001) 1.00
Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood (1999) 1.00
Separation of amino acid enantiomers and chiral amines using precolumn derivatization with (+)-1-(9-fluorenyl)ethyl chloroformate and reversed-phase liquid chromatography. Anal Chem (1987) 1.00
LiSa-2, a novel human liposarcoma cell line with a high capacity for terminal adipose differentiation. Int J Cancer (2000) 1.00
Decay-accelerating factor (DAF, CD55) in normal colorectal mucosa, adenomas and carcinomas. Br J Cancer (1992) 0.99
B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain. Int J Cancer (1987) 0.99
Analysis of chromosomal imbalances in sporadic and NF1-associated peripheral nerve sheath tumors by comparative genomic hybridization. Genes Chromosomes Cancer (1999) 0.99
Antigenic profile of mammary fibroadenoma and cystosarcoma phyllodes. A study using antibodies to estrogen- and progesterone receptors and to a panel of cell surface molecules. Pathol Res Pract (1990) 0.98
High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma. Leukemia (2007) 0.97
Chromosomal changes during progression of transitional cell carcinoma of the bladder and delineation of the amplified interval on chromosome arm 8q. Genes Chromosomes Cancer (1998) 0.97
Characteristic pattern of chromosomal gains and losses in primary large B-cell lymphomas of the gastrointestinal tract. Blood (1998) 0.96
Differential expression of beta 1 integrins in nonneoplastic smooth and striated muscle cells and in tumors derived from these cells. Am J Pathol (1994) 0.96
Differential expression of the microspike-associated protein moesin in human tissues. Eur J Cell Biol (1995) 0.96
High-level DNA amplifications are common genetic aberrations in B-cell neoplasms. Am J Pathol (1997) 0.96
Effect of aging on free amino acids and electrolytes in leg skeletal muscle. Clin Sci (Lond) (1979) 0.96
L1 adhesion molecule on human lymphocytes and monocytes: expression and involvement in binding to alpha v beta 3 integrin. Eur J Immunol (1996) 0.96
Early detachment of colon carcinoma cells during CD95(APO-1/Fas)-mediated apoptosis. I. De-adhesion from hyaluronate by shedding of CD44. J Cell Biol (1996) 0.96
Thymoma. A clinicopathologic study of 98 cases with special reference to three unusual cases. Pathol Res Pract (1985) 0.95
STAT6 activity is regulated by SOCS-1 and modulates BCL-XL expression in primary mediastinal B-cell lymphoma. Leukemia (2008) 0.95
Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma. Virchows Arch A Pathol Anat Histopathol (1990) 0.95
Vaccination with IL-12 gene-modified autologous melanoma cells: preclinical results and a first clinical phase I study. Gene Ther (1998) 0.95
Molecular-cytogenetic comparison of mucosa-associated marginal zone B-cell lymphoma and large B-cell lymphoma arising in the gastro-intestinal tract. Genes Chromosomes Cancer (2001) 0.94
Sequential induction of MHC antigens on autochthonous cells of ileum affected by Crohn's disease. Am J Pathol (1987) 0.94
t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer (2000) 0.94
FTO deficiency induces UCP-1 expression and mitochondrial uncoupling in adipocytes. Endocrinology (2013) 0.94
Microwave irradiation of paraffin-embedded tissue sensitizes the TUNEL method for in situ detection of apoptotic cells. Histochem Cell Biol (1995) 0.94
Mediastinal B-cell lymphoma: a study of its histomorphologic spectrum based on 109 cases. Hum Pathol (1999) 0.94
Segmental chromosomal aberrations and centrosome amplifications: pathogenetic mechanisms in Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma? Leukemia (2003) 0.93
Further delineation of chromosomal consensus regions in primary mediastinal B-cell lymphomas: an analysis of 37 tumor samples using high-resolution genomic profiling (array-CGH). Leukemia (2007) 0.92
MHC-II-independent CD4+ T cells induce colitis in immunodeficient RAG-/- hosts. J Immunol (2001) 0.92
CD95 ligand (CD95L) immunohistochemistry: a critical study on 12 antibodies. Cell Death Differ (2001) 0.92
Differential regulation of human T cell responsiveness by mucosal versus blood monocytes. Eur J Immunol (1996) 0.91
Pathway activation patterns in diffuse large B-cell lymphomas. Leukemia (2008) 0.91
Expression of Ki-1 antigen (CD30) in mesenchymal tumors. Cancer (1990) 0.91
CD95(APO-1/Fas)-mediated apoptosis in normal and malignant liver, colon, and hematopoietic cells. Adv Cancer Res (1998) 0.90
Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium. Br J Cancer (1993) 0.90
Expression of aminopeptidase N (CD13) in mesenchymal tumors. Am J Pathol (1990) 0.90
Nonimmune human cells can express MHC class II antigens in the absence of invariant chain--an immunohistological study on normal and chronically inflamed small intestine. Clin Exp Immunol (1988) 0.90
In vitro and clinical characterisation of a Newcastle disease virus-modified autologous tumour cell vaccine for treatment of colorectal cancer patients. Eur J Cancer (1991) 0.90
Developmentally regulated expression of metastasis-associated antigens in the rat. Cell Growth Differ (1996) 0.90
Formation of the Scandinavian Obesity Surgery Registry, SOReg. Obes Surg (2015) 0.90
Low frequency of chromosomal imbalances in anaplastic ependymomas as detected by comparative genomic hybridization. Brain Pathol (2001) 0.89
Suppression of Burkitt's lymphoma tumorigenicity in nude mice by co-inoculation of EBV-immortalized lymphoblastoid cells. Int J Cancer (1995) 0.89
Serum tenascin-C is an indicator of inflammatory bowel disease activity. Int J Colorectal Dis (2001) 0.89
Thymic medullary cells expressing B lymphocyte antigens. Hum Pathol (1988) 0.89
MR imaging of a pilomatrixoma. Pediatr Radiol (1998) 0.88
TRAIL (TNF-related apoptosis-inducing ligand) regulates adipocyte metabolism by caspase-mediated cleavage of PPARgamma. Cell Death Dis (2013) 0.88
Altered content and distribution of tenascin in colitis, colon adenoma, and colorectal carcinoma. Gastroenterology (1992) 0.88
[Merkel cell tumor of the eyelids: review of the literature and report of 2 patients]. Klin Monbl Augenheilkd (2000) 0.87
In situ expression of beta 1, beta 3 and beta 4 integrin subunits in non-neoplastic endothelium and vascular tumours. Virchows Arch (1994) 0.87
Is colorectal surveillance indicated in patients with PTEN mutations? Colorectal Dis (2012) 0.87